UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

The New England journal of medicine, 1999-01, Vol.340 (3), p.190-195

1999

Volltextzugriff (PDF)

Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2135-2138

1997

Volltextzugriff (PDF)

Atypical carcinoid of the lung. A distinct clinicopathologic entity

Chest, 1988-02, Vol.93 (2), p.370-375

1988

Volltextzugriff (PDF)

Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting: Pooled analysis of 14 clinical trials

Supportive care in cancer, 1998-09, Vol.6 (5), p.473-478

1998

Volltextzugriff (PDF)

High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association

American journal of clinical oncology, 1991-12, Vol.14 (6), p.526

1991

Volltextzugriff (PDF)

Primary lymphoma of the central nervous system: a report of 20 cases and a review of the literature

American journal of clinical oncology, 1989-04, Vol.12 (2), p.93-100

1989

Volltextzugriff (PDF)

Hypercalcemia and elevated serum calcitriol in a patient with seminoma

Archives of internal medicine (1960), 1987-12, Vol.147 (12), p.2212-2213

1987

Volltextzugriff (PDF)

Randomized, double blind, dose‐response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy

Cancer, 1997-03, Vol.79 (6), p.1216-1224

1997

Volltextzugriff (PDF)

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group

The New England journal of medicine, 1999-01, Vol.340 (3), p.190

1999

Volltextzugriff (PDF)

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group

Cancer, 1997-03, Vol.79 (6), p.1216

1997

Volltextzugriff (PDF)

High-dose 24-hour infusion of 5-florouracil in metastatic prostate cancer : a phase II trial of the piedmont oncology association

American journal of clinical oncology, 1991, Vol.14 (6), p.526-529

1991

Volltextzugriff (PDF)

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group

The cancer journal from Scientific American, 1997-01, Vol.3 (1), p.45

1997

Volltextzugriff (PDF)

The GEO 600 status

Classical and quantum gravity, 2010-04, Vol.27 (8), p.084003-084003

Grote, H

2010

Volltextzugriff (PDF)

New Frontiers in Environmental and Social Labeling

Volltextzugriff (PDF)

The status of GEO 600

Classical and quantum gravity, 2008-06, Vol.25 (11), p.114043

Grote, H

2008

Volltextzugriff (PDF)

First long-term application of squeezed states of light in a gravitational-wave observatory

Physical review letters, 2013-05, Vol.110 (18), p.181101-181101, Article 181101

2013

Volltextzugriff (PDF)

Upper limits on the amplitude of ultra-high-frequency gravitational waves from graviton to photon conversion

The European physical journal. C, Particles and fields, 2019-12, Vol.79 (12), p.1-14, Article 1032

2019

Volltextzugriff (PDF)

Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1

Human molecular genetics, 2020-08, Vol.29 (15), p.2551-2567

2020

Volltextzugriff (PDF)

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme

Acta neuropathologica, 2000-09, Vol.100 (3), p.323-331

2000

Volltextzugriff (PDF)

Novel signatures of dark matter in laser-interferometric gravitational-wave detectors

Physical review research, 2019-12, Vol.1 (3), Article 033187

2019

Volltextzugriff (PDF)

Blockchain financial geographies: Disrupting space, agency and scale

Geoforum, 2024-05, Vol.151, p.103615, Article 103615

2024

Volltextzugriff (PDF)

An experiment for observing quantum gravity phenomena using twin table-top 3D interferometers

Classical and quantum gravity, 2021-04, Vol.38 (8), p.85008

2021

Volltextzugriff (PDF)

GEO 600 and the GEO-HF upgrade program: successes and challenges

Classical and quantum gravity, 2016-03, Vol.33 (7), p.75009

2016

Volltextzugriff (PDF)

Can infant feeding choices modulate later obesity risk? [Erratum: 2009 July, v. 90, no. 1, p. 248.]

The American journal of clinical nutrition, 2009-05, Vol.89 (5), p.1502S-1508S

2009

Volltextzugriff (PDF)

1 – 25 von 1.433

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.094)
Mit Volltextzugriff
(1.143)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone

Atypical carcinoid of the lung. A distinct clinicopathologic entity

Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting: Pooled analysis of 14 clinical trials

High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association

Primary lymphoma of the central nervous system: a report of 20 cases and a review of the literature

Hypercalcemia and elevated serum calcitriol in a patient with seminoma

Randomized, double blind, dose‐response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group

High-dose 24-hour infusion of 5-florouracil in metastatic prostate cancer : a phase II trial of the piedmont oncology association

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group

The GEO 600 status

New Frontiers in Environmental and Social Labeling

The status of GEO 600

First long-term application of squeezed states of light in a gravitational-wave observatory

Upper limits on the amplitude of ultra-high-frequency gravitational waves from graviton to photon conversion

Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme

Novel signatures of dark matter in laser-interferometric gravitational-wave detectors

Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort

Blockchain financial geographies: Disrupting space, agency and scale

An experiment for observing quantum gravity phenomena using twin table-top 3D interferometers

GEO 600 and the GEO-HF upgrade program: successes and challenges

Can infant feeding choices modulate later obesity risk? [Erratum: 2009 July, v. 90, no. 1, p. 248.]

Suchergebnisse filtern